Skip to content

Clinical Effect of Tumor-Specific Total Nutrients in Patients with Adjuvant Chemotherapy after Radical Gastric Cancer Resection

Clinical Effect of Tumor-Specific Total Nutrients in Patients with Adjuvant Chemotherapy after Radical Gastric Cancer Resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088452
Enrollment
Unknown
Registered
2024-08-19
Start date
2020-01-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric carcinoma

Interventions

Tumor-specific total nutrients experimental group:Based on a regular breakfast and lunch diet, dinner was replaced with tumor-specific total nutrients
oral nutrients were required to meet at least 30% of a patient’s daily energy needs.
Tumor-specific total nutrients control group:Three regular meals

Sponsors

Hai'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
26 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) age 26–75 years; 2) the diagnosis of gastric cancer was confirmed by pathology, gastroscopy, or related examinations; 3) the gastric cancer TNM stage was ?–?, with Billroth ?gastrectomy ; 4) the patient received standard frontline adjuvant chemotherapy; 5) an expected survival period =6 months; 6) the patient and their family members signed an informed consent form to participate in this study.

Exclusion criteria

Exclusion criteria: 1) patients with dysfunction in other important organs, severe infections, various metabolic diseases, and other malignant tumors; 2) tumor recurrence and metastasis that cannot be completely removed; 3) patients with distant metastasis of the tumor; 4) individuals with contraindications to enteral nutrition; 5) patients unable to receive enteral nutrition and diet because of short bowel syndrome or intestinal obstruction; 6) patients who underwent preoperative chemotherapy or concurrent radiation therapy.

Design outcomes

Primary

MeasureTime frame
Albumin;Total protein;

Secondary

MeasureTime frame
Upper arm circumference;Triceps skinfold thickness;Grip strength;Weight;Hemoglobin;Bodyfat mass ;Transferrin;CD4+(%);CD8+(%);CD4+/CD8+;IgA;IgG;

Countries

China

Contacts

Public ContactXiumei Hua

Hai'an People's Hospital

276441941@qq.com+86 152 5067 3198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026